A controversial study showing that the blockbuster cholesterol-lowering drug Vytorin failed to slow the buildup of artery plaques more than a cheaper statin is certain to provoke questions among heart patients taking Vytorin or its sister drug Zetia.
From: www.usatoday.com
What you should know about Vytorin and Zetia
Posted by Ruslan Abuzant at 7:40 PM
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment